Works matching Cisplatin (drug interactions)

Results: 39

Interaction of anticancer drug cisplatin with guanine: Density functional theory and surface-enhanced Raman spectroscopy study.

Published in:

Biopolymers, 2003, v. 72, n. 6, p. 472, doi. 10.1002/bip.10480

By:

Giese, Bernd;
McNaughton, Don

Publication type:

Article

Chemoprotectants: A Review of their Clinical Pharmacology and Therapeutic Efficacy.

Published in:

Drugs, 1999, v. 57, n. 3, p. 293

By:

Links, M.;
Lewis, C.

Publication type:

Article

Phase IB study of sorafenib in combination with gemcitabine and cisplatin in patients with refractory solid tumors.

Published in:

Cancer Chemotherapy & Pharmacology, 2012, v. 69, n. 2, p. 333, doi. 10.1007/s00280-011-1685-x

By:

Schultheis, B.;
Kummer, G.;
Zeth, M.;
Brendel, E.;
Xia, C.;
Kornacker, M.;
Strumberg, D.

Publication type:

Article

Irinotecan–cisplatin interactions assessed in cell-based screening assays: cytotoxicity, drug accumulation and DNA adduct formation in an NSCLC cell line.

Published in:

Cancer Chemotherapy & Pharmacology, 2007, v. 60, n. 1, p. 91, doi. 10.1007/s00280-006-0353-z

By:

Zastre, Jason;
Anantha, Malathi;
Ramsay, Euan;
Bally, Marcel

Publication type:

Article

Irinotecan-cisplatin interactions assessed in cell-based screening assays: cytotoxicity, drug accumulation and DNA adduct formation in an NSCLC cell line.

Published in:

2007

By:

Zastre, Jason;
Anantha, Malathi;
Ramsay, Euan;
Bally, Marcel

Publication type:

journal article

Mass spectrometric studies on the interaction of cisplatin and insulin.

Published in:

Amino Acids, 2016, v. 48, n. 4, p. 1033, doi. 10.1007/s00726-015-2159-y

By:

Li, Jing;
Yue, Lei;
Liu, Yaqin;
Yin, Xinchi;
Yin, Qi;
Pan, Yuanjiang;
Yang, Lirong

Publication type:

Article

Triple-layered scaffold containing cisplatin and curcumin applied for cancerous bone regeneration.

Published in:

Journal of Biomaterials Applications, 2023, v. 38, n. 4, p. 500, doi. 10.1177/08853282231199313

By:

Thepsri, Nicha;
Kaewsrichan, Jasadee

Publication type:

Article

Potential of bacteriophage therapy in managing Staphylococcus aureus infections during chemotherapy for lung cancer patients.

Published in:

Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-36749-2

By:

Li, Jiaqi;
Zheng, Huangliang;
Leung, Sharon Shui Yee

Publication type:

Article

Co-Administration of Fendiline Hydrochloride Enhances Chemotherapeutic Efficacy of Cisplatin in Neuroblastoma Treatment.

Published in:

Molecules, 2020, v. 25, n. 22, p. 5234, doi. 10.3390/molecules25225234

By:

Brizzolara, Antonella;
Garbati, Patrizia;
Vella, Serena;
Calderoni, Matilde;
Quattrone, Alessandro;
Tonini, Gian Paolo;
Capasso, Mario;
Longo, Luca;
Barbieri, Raffaella;
Florio, Tullio;
Pagano, Aldo;
Faustino, M. Amparo F.

Publication type:

Article

Organoselenium Compounds as Novel Adjuvants of Chemotherapy Drugs—A Promising Approach to Fight Cancer Drug Resistance.

Published in:

Molecules, 2019, v. 24, n. 2, p. 336, doi. 10.3390/molecules24020336

By:

Spengler, Gabriella;
Gajdács, Márió;
Marć, Małgorzata Anna;
Domínguez-Álvarez, Enrique;
Sanmartín, Carmen

Publication type:

Article

Cuprous oxide nanoparticles trigger reactive oxygen species-induced apoptosis through activation of erk-dependent autophagy in bladder cancer.

Published in:

Cell Death & Disease, 2020, v. 11, n. 5, p. 1, doi. 10.1038/s41419-020-2554-5

By:

Xiong, Qiao;
Liu, Anwei;
Ren, Qian;
Xue, Yongping;
Yu, Xiaowen;
Ying, Yidie;
Gao, Hongliang;
Tan, Haoyuan;
Zhang, Zhensheng;
Li, Wei;
Zeng, Shuxiong;
Xu, Chuanliang

Publication type:

Article

Phase I trial of axitinib combined with platinum doublets in patients with advanced non-small cell lung cancer and other solid tumours.

Published in:

British Journal of Cancer, 2012, v. 107, n. 8, p. 1277, doi. 10.1038/bjc.2012.406

By:

Kozloff, M. F.;
Martin, L. P.;
Krzakowski, M.;
Samuel, T. A.;
Rado, T. A.;
Arriola, E.;
De Castro Carpeño, J.;
Herbst, R. S.;
Tarazi, J.;
Kim, S.;
Rosbrook, B.;
Tortorici, M.;
Olszanski, A. J.;
Cohen, R. B.

Publication type:

Article

Clinical Significance of Pharmacokinetic Drug Interactions Between Interferon-α and Antineoplastic Drugs.

Published in:

BioDrugs, 1999, v. 11, n. 2, p. 87, doi. 10.2165/00063030-199911020-00003

By:

Czejka, M.J.;
Schueller, J.;
Kletzl, H.;
Strauch, S.;
Pietrzak, C.

Publication type:

Article

Mitochondria as a critical target of the chemotheraputic agent cisplatin in head and neck cancer.

Published in:

Journal of Bioenergetics & Biomembranes, 2007, v. 39, n. 1, p. 43, doi. 10.1007/s10863-006-9059-5

By:

Kevin Cullen;
Zejia Yang;
Lisa Schumaker;
Zhongmin Guo

Publication type:

Article

Investigation of different methods for cisplatin loading using single-walled carbon nanotube.

Published in:

Chemical Engineering Research & Design: Transactions of the Institution of Chemical Engineers Part A, 2016, v. 112, p. 56, doi. 10.1016/j.cherd.2016.06.006

By:

Kazemi-Beydokhti, Amin;
Zeinali Heris, Saeed;
Jaafari, Mahmoud Reza

Publication type:

Article

Synthesis, crystal structures, and biological activity of aroylhydrazone di-m-chlorobenzyltin complexes.

Published in:

Journal of Biological Inorganic Chemistry (JBIC), 2024, v. 29, n. 1, p. 87, doi. 10.1007/s00775-023-02038-6

By:

Jiang, Wujiu;
Zhou, Pengfei;
Chen, Le;
Fu, Weiwei;
Tan, Yuxing

Publication type:

Article

Autophagy Inhibition Overcomes the Antagonistic Effect Between Gefitinib and Cisplatin in Epidermal Growth Factor Receptor Mutant Non--Small-Cell Lung Cancer Cells.

Published in:

2015

By:

Liu, Jia-Tao;
Li, Wen-Cheng;
Gao, Shuang;
Wang, Fang;
Li, Xiao-Qiu;
Yu, Han-Qing;
Fan, Lu-Lu;
Wei, Wei;
Wang, Hua;
Sun, Guo-Ping

Publication type:

journal article

Comparison of the combined action of oxaliplatin or cisplatin and radiation in cervical and lung cancer cells.

Published in:

International Journal of Radiation Biology, 2007, v. 83, n. 1, p. 41, doi. 10.1080/09553000601121108

By:

Rave-Fränk, Margret;
Schmidberger, Heinz;
Christiansen, Hans;
Boll, Christine;
Lehmann, Jörg;
Weiss, Elisabeth

Publication type:

Article

Pharmacogenetic variants in TPMT alter cellular responses to cisplatin in inner ear cell lines.

Published in:

PLoS ONE, 2017, v. 12, n. 4, p. 1, doi. 10.1371/journal.pone.0175711

By:

Bhavsar, Amit P.;
Gunaretnam, Erandika P.;
Li, Yuling;
Hasbullah, Jafar S.;
Carleton, Bruce C.;
Ross, Colin J. D.

Publication type:

Article

Effects of carfilzomib alone and in combination with cisplatin on the cell death in cisplatin-sensitive and cisplatin-resistant ovarian carcinoma cell lines.

Published in:

Bratislava Medical Journal / Bratislavské Lekárske Listy, 2019, v. 120, n. 6, p. 468, doi. 10.4149/BLL_2019_075

By:

S., Zarei;
J., Zavar Reza;
H., Zarei Jaliani;
M. R., Hajizadeh;
S., Sargazi;
H., Hosseinian

Publication type:

Article

Salinomycin induces cell death and differentiation in head and neck squamous cell carcinoma stem cells despite activation of epithelial-mesenchymal transition and Akt.

Published in:

BMC Cancer, 2012, v. 12, n. 1, p. 556, doi. 10.1186/1471-2407-12-556

By:

Kuo, Selena Z.;
Blair, Katherine J.;
Rahimy, Elham;
Kiang, Alan;
Abhold, Eric;
Fan, Jian-Bing;
Wang-Rodriguez, Jessica;
Altuna, Xabier;
Ongkeko, Weg M.

Publication type:

Article

Effect of antioxidants on cisplatin-induced cytotoxicity and oxidative stress in colon cancer cells.

Published in:

EurAsian Journal of Biosciences, 2020, v. 14, n. 2, p. 5375

By:

AlSaady, Teeb Ali;
Madlum, Kaiser N.;
Obied, Hamid Naji

Publication type:

Article

Synergistic or Additive Pharmacological Interactions between Magnoflorine and Cisplatin in Human Cancer Cells of Different Histological Origin.

Published in:

International Journal of Molecular Sciences, 2020, v. 21, n. 8, p. 2848, doi. 10.3390/ijms21082848

By:

Okon, Estera;
Luszczki, Jarogniew J.;
Kukula-Koch, Wirginia;
Halasa, Marta;
Jarzab, Agata;
Khurelbat, Daariimaa;
Stepulak, Andrzej;
Wawruszak, Anna

Publication type:

Article

Concomitant lansoprazole ameliorates cisplatin‐induced nephrotoxicity by inhibiting renal organic cation transporter 2 in rats.

Published in:

Biopharmaceutics & Drug Disposition, 2020, v. 41, n. 6, p. 239, doi. 10.1002/bdd.2242

By:

Hiramatsu, Shun‐ichi;
Ikemura, Kenji;
Fujisawa, Yutaka;
Iwamoto, Takuya;
Okuda, Masahiro

Publication type:

Article

Continuum Modelling for Encapsulation of Anticancer Drugs inside Nanotubes.

Published in:

Mathematics (2227-7390), 2021, v. 9, n. 19, p. 2469, doi. 10.3390/math9192469

By:

Alshehri, Mansoor H.

Publication type:

Article

Phase I/II and pharmacokinetic study of intravenous vinflunine in combination with cisplatin for the treatment of chemonaive patients with advanced non-small-cell lung cancer.

Published in:

2010

By:

Souquet PJ;
Krzakowski M;
Ramlau R;
Sun XS;
Lopez-Vivanco G;
Puozzo C;
Pouget JC;
Pinel MC;
Rosell R

Publication type:

Journal Article

Interfacial properties and in vitro cytotoxic effects of surface-modified near infrared absorbing Au-Au2S nanoparticles.

Published in:

Journal of Materials Science: Materials in Medicine, 2009, v. 20, n. 10, p. 2091, doi. 10.1007/s10856-009-3779-0

By:

Mei Chee Tan;
Ying, Jackie Y.;
Gan Moog Chow

Publication type:

Article

Direct determination of the binding sites of cisplatin on insulin-like growth factor-1 by top-down mass spectrometry.

Published in:

Journal of Biological Inorganic Chemistry (JBIC), 2015, v. 20, n. 1, p. 1, doi. 10.1007/s00775-014-1202-x

By:

Zhang, Ningbo;
Liu, Huan;
Cui, Meng;
Du, Yonggang;
Liu, Zhiqiang;
Liu, Shuying

Publication type:

Article

Reactivity of platinum-based antitumor drugs towards a Met- and His-rich 20mer peptide corresponding to the N-terminal domain of human copper transporter 1.

Published in:

Journal of Biological Inorganic Chemistry (JBIC), 2009, v. 14, n. 8, p. 1313, doi. 10.1007/s00775-009-0576-7

By:

Zhengyi Wu;
Qin Liu;
Xiao Liang;
Xiaoliang Yang;
Ningyan Wang;
Xinghao Wang;
Hongzhe Sun;
Yi Lu;
Zijian Guo

Publication type:

Article

Impact of V9302, a Competitive Antagonist of Transmembrane Glutamine Flux on Reversal of Resistance in Breast Cancer Cell Lines.

Published in:

Pharmaceutics, 2024, v. 16, n. 7, p. 877, doi. 10.3390/pharmaceutics16070877

By:

Szemerédi, Nikoletta;
Schelz, Zsuzsanna;
Horvath, Dária Antónia;
Rácz, Bálint;
Szatmári, András G.;
Muddather, Hiba F.;
Bózsity, Noémi;
Zupkó, István;
Spengler, Gabriella

Publication type:

Article

Therapeutic Implications of Ceritinib in Cholangiocarcinoma beyond ALK Expression and Mutation.

Published in:

Pharmaceuticals (14248247), 2024, v. 17, n. 2, p. 197, doi. 10.3390/ph17020197

By:

Myint, Kyaw Zwar;
Balasubramanian, Brinda;
Venkatraman, Simran;
Phimsen, Suchada;
Sripramote, Supisara;
Jantra, Jeranan;
Choeiphuk, Chaiwat;
Mingphruedhi, Somkit;
Muangkaew, Paramin;
Rungsakulkij, Narongsak;
Tangtawee, Pongsatorn;
Suragul, Wikran;
Farquharson, Watoo Vassanasiri;
Wongprasert, Kanokpan;
Chutipongtanate, Somchai;
Sanvarinda, Pimtip;
Ponpuak, Marisa;
Poungvarin, Naravat;
Janvilisri, Tavan;
Suthiphongchai, Tuangporn

Publication type:

Article

Identification of Cisplatin-Binding Proteins Using Agarose Conjugates of Platinum Compounds.

Published in:

PLoS ONE, 2013, v. 8, n. 6, p. 1, doi. 10.1371/journal.pone.0066220

By:

Karasawa, Takatoshi;
Sibrian-Vazquez, Martha;
Strongin, Robert M.;
Steyger, Peter S.

Publication type:

Article

Phase I studies of imatinib mesylate combined with cisplatin and irinotecan in patients with small cell lung carcinoma.

Published in:

2006

By:

Johnson, Faye M;
Krug, Lee M;
Tran, Hai T;
Shoaf, Stephanie;
Prieto, Victor G;
Tamboli, Pheroze;
Peeples, Beverly;
Patel, Jyoti;
Glisson, Bonnie S

Publication type:

journal article

Phase I studies of imatinib mesylate combined with cisplatin and irinotecan in patients with small cell lung carcinoma.

Published in:

Cancer (0008543X), 2006, v. 106, n. 2, p. 366

By:

Faye M. Johnson;
Lee M. Krug;
Hai T. Tran;
Stephanie Shoaf;
Victor G. Prieto;
Pheroze Tamboli;
Beverly Peeples;
Jyoti Patel;
Bonnie S. Glisson

Publication type:

Article

Phase I and pharmacokinetic study of the novel chemoprotector BNP7787 in combination with cisplatin and attempt to eliminate the hydration schedule.

Published in:

British Journal of Cancer, 2005, v. 92, n. 9, p. 1636, doi. 10.1038/sj.bjc.6602553

By:

Boven, E.;
Westerman, M.;
van Groeningen, C. J.;
Verschraagen, M.;
Ruijter, R.;
Zegers, I.;
van der Vijgh, W. J. F.;
Giaccone, G.

Publication type:

Article

Effect of the coffee ingredient cafestol on head and neck squamous cell carcinoma cell lines.

Published in:

Strahlentherapie und Onkologie, 2015, v. 191, n. 6, p. 511, doi. 10.1007/s00066-014-0807-x

By:

Kotowski, Ulana;
Heiduschka, Gregor;
Seemann, Rudolf;
Eckl-Dorna, Julia;
Schmid, Rainer;
Kranebitter, Veronika;
Stanisz, Isabella;
Brunner, Markus;
Lill, Claudia;
Thurnher, Dietmar

Publication type:

Article

Na+/K+-ATPase inhibition by cisplatin and consequences for cisplatin nephrotoxicity.

Published in:

Biomedical Papers of the Medical Faculty of Palacky University in Olomouc, 2014, v. 158, n. 2, p. 194, doi. 10.5507/bp.2014.018

By:

Kubala, Martin;
Geleticova, Jaroslava;
Huliciak, Miroslav;
Zatloukalova, Martina;
Vacek, Jan;
Sebela, Marek

Publication type:

Article

Synergistic cooperation between sunitinib and cisplatin promotes apoptotic cell death in human medullary thyroid cancer.

Published in:

2014

By:

Lopergolo, Alessia;
Nicolini, Valentina;
Favini, Enrica;
Dal Bo, Laura;
Tortoreto, Monica;
Cominetti, Denis;
Folini, Marco;
Perego, Paola;
Castiglioni, Vittoria;
Scanziani, Eugenio;
Borrello, Maria Grazia;
Zaffaroni, Nadia;
Cassinelli, Giuliana;
Lanzi, Cinzia

Publication type:

journal article

Antiproliferative activity of bortezomib alone and in combination with cisplatin or docetaxel in head and neck squamous cell carcinoma cell lines.

Published in:

Journal of Cancer Research & Clinical Oncology, 2008, v. 134, n. 3, p. 323, doi. 10.1007/s00432-007-0287-9

By:

Wagenblast, Jens;
Hambek, Markus;
Baghi, Mehran;
Gstöttner, Wolfgang;
Strebhardt, Klaus;
Ackermann, Hanns;
Knecht, Rainald

Publication type:

Article

Works matching Cisplatin (drug interactions)

Interaction of anticancer drug cisplatin with guanine: Density functional theory and surface-enhanced Raman spectroscopy study.

Chemoprotectants: A Review of their Clinical Pharmacology and Therapeutic Efficacy.

Phase IB study of sorafenib in combination with gemcitabine and cisplatin in patients with refractory solid tumors.

Irinotecan–cisplatin interactions assessed in cell-based screening assays: cytotoxicity, drug accumulation and DNA adduct formation in an NSCLC cell line.

Irinotecan-cisplatin interactions assessed in cell-based screening assays: cytotoxicity, drug accumulation and DNA adduct formation in an NSCLC cell line.

Mass spectrometric studies on the interaction of cisplatin and insulin.

Triple-layered scaffold containing cisplatin and curcumin applied for cancerous bone regeneration.

Potential of bacteriophage therapy in managing Staphylococcus aureus infections during chemotherapy for lung cancer patients.

Co-Administration of Fendiline Hydrochloride Enhances Chemotherapeutic Efficacy of Cisplatin in Neuroblastoma Treatment.

Organoselenium Compounds as Novel Adjuvants of Chemotherapy Drugs—A Promising Approach to Fight Cancer Drug Resistance.

Cuprous oxide nanoparticles trigger reactive oxygen species-induced apoptosis through activation of erk-dependent autophagy in bladder cancer.

Phase I trial of axitinib combined with platinum doublets in patients with advanced non-small cell lung cancer and other solid tumours.

Clinical Significance of Pharmacokinetic Drug Interactions Between Interferon-α and Antineoplastic Drugs.

Mitochondria as a critical target of the chemotheraputic agent cisplatin in head and neck cancer.

Investigation of different methods for cisplatin loading using single-walled carbon nanotube.

Synthesis, crystal structures, and biological activity of aroylhydrazone di-m-chlorobenzyltin complexes.

Autophagy Inhibition Overcomes the Antagonistic Effect Between Gefitinib and Cisplatin in Epidermal Growth Factor Receptor Mutant Non--Small-Cell Lung Cancer Cells.

Comparison of the combined action of oxaliplatin or cisplatin and radiation in cervical and lung cancer cells.

Pharmacogenetic variants in TPMT alter cellular responses to cisplatin in inner ear cell lines.

Effects of carfilzomib alone and in combination with cisplatin on the cell death in cisplatin-sensitive and cisplatin-resistant ovarian carcinoma cell lines.

Salinomycin induces cell death and differentiation in head and neck squamous cell carcinoma stem cells despite activation of epithelial-mesenchymal transition and Akt.

Effect of antioxidants on cisplatin-induced cytotoxicity and oxidative stress in colon cancer cells.

Synergistic or Additive Pharmacological Interactions between Magnoflorine and Cisplatin in Human Cancer Cells of Different Histological Origin.

Concomitant lansoprazole ameliorates cisplatin‐induced nephrotoxicity by inhibiting renal organic cation transporter 2 in rats.

Continuum Modelling for Encapsulation of Anticancer Drugs inside Nanotubes.

Phase I/II and pharmacokinetic study of intravenous vinflunine in combination with cisplatin for the treatment of chemonaive patients with advanced non-small-cell lung cancer.

Interfacial properties and in vitro cytotoxic effects of surface-modified near infrared absorbing Au-Au<sub>2</sub>S nanoparticles.

Direct determination of the binding sites of cisplatin on insulin-like growth factor-1 by top-down mass spectrometry.

Reactivity of platinum-based antitumor drugs towards a Met- and His-rich 20mer peptide corresponding to the N-terminal domain of human copper transporter 1.

Impact of V9302, a Competitive Antagonist of Transmembrane Glutamine Flux on Reversal of Resistance in Breast Cancer Cell Lines.

Therapeutic Implications of Ceritinib in Cholangiocarcinoma beyond ALK Expression and Mutation.

Identification of Cisplatin-Binding Proteins Using Agarose Conjugates of Platinum Compounds.

Phase I studies of imatinib mesylate combined with cisplatin and irinotecan in patients with small cell lung carcinoma.

Phase I studies of imatinib mesylate combined with cisplatin and irinotecan in patients with small cell lung carcinoma.

Phase I and pharmacokinetic study of the novel chemoprotector BNP7787 in combination with cisplatin and attempt to eliminate the hydration schedule.

Effect of the coffee ingredient cafestol on head and neck squamous cell carcinoma cell lines.

Na<sup>+</sup>/K<sup>+</sup>-ATPase inhibition by cisplatin and consequences for cisplatin nephrotoxicity.

Synergistic cooperation between sunitinib and cisplatin promotes apoptotic cell death in human medullary thyroid cancer.

Antiproliferative activity of bortezomib alone and in combination with cisplatin or docetaxel in head and neck squamous cell carcinoma cell lines.